专业测试市场——增长、趋势、COVID-19 的影响、预测 (2023-2028)

在预测期内，专业测试市场预计将以 12% 的复合年增长率增长。

市场增长的主要驱动力是传染病和罕见病等病例的增加。 据欧盟委员会称，欧洲地区约有 27 至 3600 万人受到罕见病的影响。 根据疾病控制和预防中心的数据，2017 年大约有 54,285 例沙门氏菌病例。 因此，这种日益增加的罕见疾病负担预计将在预测期内增加对专业检测市场增长的需求。

专项检测市场趋势

市场细分预计在预测期内将出现显着的市场增长

预计在预测期内，肿瘤学在专业检测市场将呈现健康增长。 癌症早期诊断和治疗的重要性日益增加，将对该领域的市场增长产生积极影响。 据世界卫生组织称，癌症是全球第二大死因之一。 2018 年，全球报告了约 180 万例新癌症病例。 最常见的癌症类型是肺癌、乳腺癌和前列腺癌。

此外，研发活动投资的增加预计将推动测试需求。 根据欧洲製药工业协会联合会的数据，2017年全球製药行业整体销售额约为8526.47亿美元。 因此，上述因素有望推动该领域的市场增长。

预计北美将占据很大的市场份额，预计在预测期内也会如此

由于研发活动和投资的增加，预计北美将成为专业测试市场的主导地区。 根据国家罕见病组织的数据，大约有 3000 万人患有某种形式的疾病（2019 年）。 近十分之一的美国人患有罕见病，其中一半以上是儿童。 根据美国研究与製药商协会的数据，2018 年美国生物製药公司的研发支出约为 796 亿美元。 因此，由于罕见疾病负担的增加和研发活动投资的增加，预计对专业测试的需求将推动该地区的市场增长。

专业检测市场竞争分析

在专业测试市场运营的知名公司包括 American Esoteric Laboratories、Quest Diagnostics、Laboratory Corporation of America、bioMontr Labs、Arup Laboratories、Miraca Holdings Inc、Fulgent Genetics Inc、Nordic Laboratories 和 Grifols, S.A. 等。

其他好处

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第一章介绍

• 调查先决条件
• 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动力
  • 增加慢性病负担
  • 罕见病增加
  • 研发费用增加
• 市场製约因素
  • 严格的监管框架
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分

• 按测试类型
  • 内分泌学
  • 感染
  • 肿瘤科
  • 神经学
  • 毒理学
  • 其他
• 按技术
  • 流式细胞术
  • 化学发光免疫分析
  • 质谱
  • 放射免疫分析
  • 其他
• 按地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲地区
  • 南美洲地区
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • American Esoteric Laboratories
  • Arup Laboratories
  • bioMontr Labs
  • Fulgent Genetics Inc.
  • Grifols, S.A.
  • Laboratory Corporation of America
  • Miraca Holdings Inc.
  • Nordic Laboratories
  • Quest Diagnostics

第7章 市场机会今后动向

The esoteric testing market is expected to register a 12 % of CAGR over the forecast period. The key contributors in the market growth are rising cases of infectious and rare diseases and other diseases. According to the European Commission, approximately 27 to 36 million people suffer from rare disease in European region. Also, according to the Centre for Disease Control and Prevnetion, 2017, the number of cases of salmonella were around 54,285. Hence this growing burden of rare diseases is expected to increase the demand for esoteric testing market growth during the forecast period.

Esoteric Testing Market Trends

Oncology Segment is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Oncology is expected to show a healthy growth in the Esoteric Testing Market during the forecast period. The rising importance of early diagnosis and treatment for cancer will impact positively on the market growth in this segment. According to the World Health Organization, cancer is one of the second leading cause of death worldwide. In 2018, around 1.8 million new cases were reported with cancer globally. The most common type of cancers are lung, breast and prostate cancer.

Furthermore, the increasing investments of R&D activities is expected to drive the demand of testing. According to the European Federation of Pharmaceutical Industries and Associations, 2017, the overall sales of pharmaceutical industry worldwide was recorded to be approximately 852,647 million USD. Hence, the aforementioned factors are expected to boost the market growth in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Esoteric Testing market owing to increasing number of R&D activities and investments on it. As per the data of National Organization of Rare Diseases, around 30 million people were suffering from some type of diseases (2019). Also, almost one out of ten individuals in America have rare diseases and more than half of these are children. According to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies was around 79.6 billion USD in United States. Thus, with growing burden of rare diseases and increasing investment into research and development activities the demand for esoteric testing is expected to propel the market growth in this region.

Esoteric Testing Market Competitive Analysis

Some of the well-known companies that are operating in Esoteric Testing market include American Esoteric Laboratories, Quest Diagnostics, Laboratory Corporation of America, bioMontr Labs, Arup Laboratories, Miraca Holdings Inc., Fulgent Genetics Inc., Nordic Laboratories and Grifols, S.A.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Burden of Chronic Diseases
  • 4.2.2 Rising Cases of Rare Diseases
  • 4.2.3 Increasing Spending in Research & Development Activities
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulatory Framework
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Test Type
  • 5.1.1 Endocrinology
  • 5.1.2 Infectious Disease
  • 5.1.3 Oncology
  • 5.1.4 Neurology
  • 5.1.5 Toxicology
  • 5.1.6 Others
• 5.2 By Technology
  • 5.2.1 Flow Cytometry
  • 5.2.2 Chemiluminescence Immunoassay
  • 5.2.3 Mass Spectrometry
  • 5.2.4 Radio Immunoassay
  • 5.2.5 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 American Esoteric Laboratories
  • 6.1.2 Arup Laboratories
  • 6.1.3 bioMontr Labs
  • 6.1.4 Fulgent Genetics Inc.
  • 6.1.5 Grifols, S.A.
  • 6.1.6 Laboratory Corporation of America
  • 6.1.7 Miraca Holdings Inc.
  • 6.1.8 Nordic Laboratories
  • 6.1.9 Quest Diagnostics

7 MARKET OPPORTUNITIES AND FUTURE TRENDS